5610823 TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 1B CROSSWALK-A TRIAL EVALUATING THE SAFETY OF CROVALIMAB FOR THE MANAGEMENT OF ACUTE UNCOMPLICATED VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD)

5610823 TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 1B CROSSWALK-A TRIAL EVALUATING THE SAFETY OF CROVALIMAB FOR THE MANAGEMENT OF ACUTE UNCOMPLICATED VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD)

Bibliographic Details
Main Authors: P. Bartolucci, K.I. Ataga, M. Callaghan, L. De Franceschi, C. Minniti, A. Alexandrou, D.-.C. Imbs, R.P. Fox, H. Patel, A. Sostelly, J. Schimmel
Format: Article
Language:English
Published: Wiley 2023-04-01
Series:HemaSphere
Online Access:http://journals.lww.com/10.1097/01.HS9.0000928292.81037.b2

Internet

http://journals.lww.com/10.1097/01.HS9.0000928292.81037.b2

Similar Items